Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

1.

Alberta Provincial Pediatric EnTeric Infection TEam (APPETITE): epidemiology, emerging organisms, and economics.

Freedman SB, Lee BE, Louie M, Pang XL, Ali S, Chuck A, Chui L, Currie GR, Dickinson J, Drews SJ, Eltorki M, Graham T, Jiang X, Johnson DW, Kellner J, Lavoie M, MacDonald J, MacDonald S, Svenson LW, Talbot J, Tarr P, Tellier R, Vanderkooi OG.

BMC Pediatr. 2015 Jul 31;15(1):89.

2.

High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).

Kingwell E, Zhu F, Marrie RA, Fisk JD, Wolfson C, Warren S, Profetto-McGrath J, Svenson LW, Jette N, Bhan V, Yu BN, Elliott L, Tremlett H.

J Neurol. 2015 Jul 24. [Epub ahead of print]

PMID:
26205633
3.

Development of the Standards of Reporting of Neurological Disorders (STROND) checklist: A guideline for the reporting of incidence and prevalence studies in neuroepidemiology.

Bennett DA, Brayne C, Feigin VL, Barker-Collo S, Brainin M, Davis D, Gallo V, Jetté N, Karch A, Kurtzke JF, Lavados PM, Logroscino G, Nagel G, Preux PM, Rothwell PM, Svenson LW.

Neurology. 2015 Jul 10. pii: 10.1212/WNL.0000000000001866. [Epub ahead of print]

PMID:
26163431
4.

Development of the standards of reporting of neurological disorders (STROND) checklist: a guideline for the reporting of incidence and prevalence studies in neuroepidemiology.

Bennett DA, Brayne C, Feigin VL, Barker-Collo S, Brainin M, Davis D, Gallo V, Jetté N, Karch A, Kurtzke JF, Lavados PM, Logroscino G, Nagel G, Preux PM, Rothwell PM, Svenson LW.

Eur J Epidemiol. 2015 Jul;30(7):569-76. doi: 10.1007/s10654-015-0034-5. Epub 2015 Jun 19.

PMID:
26088602
5.

Refining hypertension surveillance to account for potentially misclassified cases.

Peng M, Chen G, Lix LM, McAlister FA, Tu K, Campbell NR, Hemmelgarn BR, Svenson LW, Quan H; Hypertension Outcomes Surveillance Team.

PLoS One. 2015 Mar 24;10(3):e0119186. doi: 10.1371/journal.pone.0119186. eCollection 2015.

6.

Herpes zoster vaccine (HZV): utilization and coverage 2009 - 2013, Alberta, Canada.

Liu XC, Simmonds KA, Russell ML, Svenson LW.

BMC Public Health. 2014 Oct 23;14:1098. doi: 10.1186/1471-2458-14-1098.

7.

Mining rich health data from Canadian physician claims: features and face validity.

Cunningham CT, Cai P, Topps D, Svenson LW, Jetté N, Quan H.

BMC Res Notes. 2014 Oct 1;7:682. doi: 10.1186/1756-0500-7-682.

8.

The prevalence of systemic autoimmune rheumatic diseases in Canadian pediatric populations: administrative database estimates.

Shiff NJ, Lix LM, Joseph L, Duffy C, Tucker LB, Svenson LW, Belisle P, Bernatsky S.

Rheumatol Int. 2015 Mar;35(3):569-73. doi: 10.1007/s00296-014-3136-6. Epub 2014 Sep 26.

PMID:
25257764
9.

The incidence rate of colectomy for medically refractory ulcerative colitis has declined in parallel with increasing anti-TNF use: a time-trend study.

Reich KM, Chang HJ, Rezaie A, Wang H, Goodman KJ, Kaplan GG, Svenson LW, Lees G, Fedorak RN, Kroeker KI.

Aliment Pharmacol Ther. 2014 Sep;40(6):629-38. doi: 10.1111/apt.12873. Epub 2014 Jul 13.

PMID:
25039715
10.

Chronic inflammatory arthritis prevalence estimates for children and adolescents in three Canadian provinces.

Shiff NJ, Lix LM, Oen K, Joseph L, Duffy C, Stringer E, Tucker LB, Svenson LW, Belisle P, Bernatsky S.

Rheumatol Int. 2015 Feb;35(2):345-50. doi: 10.1007/s00296-014-3085-0. Epub 2014 Jul 15.

PMID:
25023756
11.

Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.

MacDonald SE, Dover DC, Simmonds KA, Svenson LW.

CMAJ. 2014 Aug 5;186(11):824-9. doi: 10.1503/cmaj.140078. Epub 2014 Jun 9.

12.

Assessing the burden of hospitalized and community-care heart failure in Canada.

Blais C, Dai S, Waters C, Robitaille C, Smith M, Svenson LW, Reimer K, Casey J, Puchtinger R, Johansen H, Gurevich Y, Lix LM, Quan H, Tu K.

Can J Cardiol. 2014 Mar;30(3):352-8. doi: 10.1016/j.cjca.2013.12.013. Epub 2013 Dec 20.

PMID:
24565257
13.

Enhancing capacity for risk factor surveillance at the regional/local level: a follow-up review of the findings of the Canadian Think Tank Forum after 4 years.

Choi BC, Decou ML, Rasali D, Martens PJ, Mancuso M, Plotnikoff RC, Neudorf C, Thanos J, Svenson LW, Denny K, Orpana H, Stewart P, King M, Griffith J, Erickson T, van Dorp R, White D, Ali A.

Arch Public Health. 2014 Jan 22;72(1):2. doi: 10.1186/2049-3258-72-2.

14.

The role of systematic reviews and meta-analyses of incidence and prevalence studies in neuroepidemiology.

Fiest KM, Pringsheim T, Patten SB, Svenson LW, Jetté N.

Neuroepidemiology. 2014;42(1):16-24. doi: 10.1159/000355533. Epub 2013 Dec 12.

15.

Surveillance of ischemic heart disease should include physician billing claims: population-based evidence from administrative health data across seven Canadian provinces.

Robitaille C, Bancej C, Dai S, Tu K, Rasali D, Blais C, Plante C, Smith M, Svenson LW, Reimer K, Casey J, Puchtinger R, Johansen H, Gurevich Y, Waters C, Lix LM, Quan H.

BMC Cardiovasc Disord. 2013 Oct 20;13:88. doi: 10.1186/1471-2261-13-88.

16.

Shingles in Alberta: before and after publicly funded varicella vaccination.

Russell ML, Dover DC, Simmonds KA, Svenson LW.

Vaccine. 2014 Oct 29;32(47):6319-24. doi: 10.1016/j.vaccine.2013.09.018. Epub 2013 Oct 4.

17.

Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study.

Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Wolfson C, Patten SB, Svenson LW, Tremlett H, Fisk J, Blanchard JF.

Mult Scler Relat Disord. 2013 Oct;2(4):355-61. doi: 10.1016/j.msard.2013.03.001. Epub 2013 Apr 2.

18.

Mental comorbidity and multiple sclerosis: validating administrative data to support population-based surveillance.

Marrie RA, Fisk JD, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Evans C, Wolfson C, Svenson LW, Tremlett H, Blanchard JF, Patten SB; CIHR Team in the Epidemiology and Impact of Comorbidity on Multiple Sclerosis.

BMC Neurol. 2013 Feb 6;13:16. doi: 10.1186/1471-2377-13-16.

19.

The utility of administrative data for surveillance of comorbidity in multiple sclerosis: a validation study.

Marrie RA, Yu BN, Leung S, Elliott L, Caetano P, Warren S, Wolfson C, Patten SB, Svenson LW, Tremlett H, Fisk J, Blanchard JF; CIHR Team in the Epidemiology and Impact of Comomrbidity on Multiple Sclerosis.

Neuroepidemiology. 2013;40(2):85-92. doi: 10.1159/000343188. Epub 2012 Oct 24.

20.

Spatio-temporal scan statistics for the detection of outbreaks involving common molecular subtypes: using human cases of Escherichia coli O157:H7 provincial PFGE pattern 8 (National Designation ECXAI.0001) in Alberta as an example.

So HC, Pearl DL, von Königslöw T, Louie M, Chui L, Svenson LW.

Zoonoses Public Health. 2013 Aug;60(5):341-8. doi: 10.1111/zph.12012. Epub 2012 Sep 7.

PMID:
22958357
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk